Cargando…
Implanted markers prior to neoadjuvant chemotherapy: preliminary report
Autor principal: | Allan for the Dartford Breast Care Team, DM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300335/ http://dx.doi.org/10.1186/bcr234 |
Ejemplares similares
-
Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012) -
Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
por: Bugiantella, W, et al.
Publicado: (2009) -
Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
por: Cedeño, Heidy, et al.
Publicado: (2007) -
Our experience in using magnetic resonance imaging (MRI) as an adjunct to mammography and ultrasound in assessing response to neoadjuvant chemotherapy
por: Dall, B, et al.
Publicado: (2002) -
Effect of anthracyclin-based neoadjuvant chemotherapy on disseminated tumor cells in breast cancer patients: an immunocytologic and molecular approach
por: Jäger, CM, et al.
Publicado: (2001)